spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Takeda Pharmaceutical 

 HSMN NewsFeed - 3 Sep 2024
Forward Therapeutics Welcomes Ulrich Thienel, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2024
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2024
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Aug 2023
Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Apr 2023
Kyowa Kirin Appoints Pharma Industry Leader Steve Schaefer as President, North America to Manage Next Phase of Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Dec 2022
Corza Medical Announces Key Executive Appointments
Devices Personnel
 HSMN NewsFeed - 7 Sep 2022
COUR Pharmaceuticals Announces $30M Financing Led by Alpha Wave Ventures
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Jul 2022
BridGene Biosciences Announces $38.5 Million Series B Financing to Further Develop Its Next Generation Chemoproteomics Platform and First-in-Class Oncology Drugs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Jan 2022
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Dec 2021
Orna Therapeutics Expands Leadership Team with Key Executive Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Dec 2021
Corbus Pharmaceuticals Appoints Rachael Brake, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2021
U.S. FDA Accepts COUR Pharmaceuticals Investigational New Drug Application (IND) for a Proof-of-Concept Study for the Treatment of Primary Biliary Cholangitis (PBC)
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jul 2021
Corium Launches Innovative ADHD Treatment AZSTARYS(TM) (serdexmethylphenidate and dexmethylphenidate) in the U.S. for Patients Age 6 Years and Older
Biopharmaceutical Neurology Product Launch
 HSMN NewsFeed - 3 May 2021
Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Feb 2021
Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Dec 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 1 Dec 2020
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
Biopharmaceutical Personnel
 HSMN NewsFeed - 16 Sep 2020
Cygnal Therapeutics Expands Leadership Team with Appointment of John A. Wagner, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2020
Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion
Devices Venture Capital
 HSMN NewsFeed - 25 Jun 2020
Enterome Completes €46.3 Million ($52.6 Million) Financing to Progress the Clinical Development of Its Therapeutic Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 May 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2020
Protalix BioTherapeutics Announces Positive Topline Results from the BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 16 Apr 2020
Digital Therapeutics Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 9 Jan 2020
Presage Receives FDA Clearance of First IND Application for Trial to Evaluate Investigational Oncology Agents with CIVO(TM) Technology
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Oct 2019
ImaginAb signs multi-party collaboration agreement with three global pharmaceutical companies to help further develop company's CD8 ImmunoPET technology
Biopharmaceuticals Oncology Radiology
 HSMN NewsFeed - 1 Oct 2019
Nektar Announces Key Executive Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Jul 2019
InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2019
U.S. FDA Approves GATTEX(R) (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 20 Mar 2019
Petra Pharma announces licensing agreement with Takeda Pharmaceutical Company
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Feb 2019
Kallyope Inc. Appoints Brett Lauring As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2018
Astellas Promotes Lei Ding to vice president, Payer Strategy, Contracts, and Pricing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jun 2018
Nordic Nanovector Appoints Eduardo Bravo as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jun 2018
StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 25 Apr 2018
MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2018
Clarus Appoints Former Ariad CEO Paris Panayiotopoulos as Operating Partner and Member of its Investment Team
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Apr 2018
Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2018
Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jan 2018
Disarm Therapeutics Appoints Thomas Engber as Senior Vice President, Head of Neuropharmacology and Translational Sciences
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Nov 2017
Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda(R) (Lurasidone Hydrochloride) in Europe
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 17 Aug 2017
Hikma Announces Expanded Licensing Agreement with Takeda for New Products in the Middle East and North Africa
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 4 Aug 2017
Biohaven Appoints Julia P. Gregory to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Jun 2017
Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix(R) (vortioxetine) sNDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jun 2017
Merrimack Announces Expansion of Senior Management Team with Appointment of Sergio Santillana as Chief Medical Officer and Ellen Forest as Head of Human Resources
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 May 2017
Takeda and GammaDelta Therapeutics Announce Collaboration to Advance Tissue-derived gamma delta (γδ) T Cells
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Apr 2017
Axovant Sciences Announces Appointment of Dr. David Hung as Chief Executive Officer and Expansion of Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 27 Mar 2017
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2017
SutroVax Announces Closing of $64M via Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 1 Mar 2017
José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems
Devices Oncology Personnel
 HSMN NewsFeed - 28 Nov 2016
Conditional Approval from the European Commission to Treat Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Aug 2016
Takeda Receives Marketing Authorization in Canada for NINLARO(TM) (ixazomib) in Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Jul 2016
Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Mar 2016
Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jan 2016
NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Nov 2015
Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan
Biopharmaceuticals Generics
 HSMN NewsFeed - 21 Oct 2015
Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Sep 2015
Teva Announces Approval of COPAXONE(R) in Japan for the Prevention of Relapse of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 30 Jul 2015
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2015
Baxalta Appoints Two New Directors to the Board, Further Diversifying With Strong Biopharmaceutical Leadership Experience
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jul 2015
Tadataka Yamada, Ph.D., Former Head of GlaxoSmithKline and Takeda R&D, Re-Joins Frazier Healthcare
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 9 Jun 2015
Tarsis Lopez joins Astellas Corporate Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2015
Takeda Announces Appointment of New President of U.S. Business Unit
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2015
Mersana Raises $35 Million in Series B Financing and Appoints Anna Protopapas as President and Chief Executive Officer
Devices Drug Delivery Venture Capital Personnel
 HSMN NewsFeed - 9 Feb 2015
PerkinElmer Elects Sylvie Grégoire to its Board of Directors
Devices Personnel
 HSMN NewsFeed - 15 Dec 2014
Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Sep 2014
AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Sep 2014
AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2014
AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2014
Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Jun 2014
Takeda Announces Termination of Orteronel (TAK-700) Development for Prostate Cancer in Japan, U.S.A. and Europe
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Apr 2014
Takeda Responds to Verdict in Diabetes Drug Case
Biopharmaceuticals Endocrinology Litigation
 HSMN NewsFeed - 10 Mar 2014
Intra-Cellular Therapies Announces the Appointment of Juan Sanchez, M.D., as Vice President of Corporate Communications and Investor Relations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 29 Jan 2014
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jan 2014
Seattle Genetics Appoints John A. Orwin to Board of Directors
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 7 Jan 2014
AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Dec 2013
Takeda Announces Exclusive License and Option Agreement with Natrogen for Development of Natura-alpha for Inflammatory Bowel Disease
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 18 Dec 2013
Takeda Launches New Subsidiary in Israel
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2013
Apricus Elects Kleanthis G. Xanthopoulos, Ph.D. as New Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2013
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 2 Dec 2013
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Nov 2013
Apricus and Laboratoires Majorelle Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream Vitaros(R) in France, Monaco and Certain African Countries
Biopharmaceuticals Urology Licensing
 HSMN NewsFeed - 29 Oct 2013
AMAG Pharmaceuticals Appoints Robert F. Kaper, M.D. as Senior Vice President of Medical and Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Aug 2013
European Commission Approves VELCADE(R) as a Frontline Induction Therapy before Stem Cell Transplantation
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 Jul 2013
AMAG Pharmaceuticals Appoints Carol Satler, M.D., Ph.D. as Senior Vice President of Medical and Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2013
Pfizer Provides Update on Global Regulatory Approvals and Launches of XELJANZ(R) (tofacitinib citrate) for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Jun 2013
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2013
Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Apr 2013
BIND Therapeutics Appoints Gregory I. Berk, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2013
XELJANZ(R) (tofacitinib citrate) Approved in Japan for the Treatment of Adults with Rheumatoid Arthritis (RA)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Mar 2013
Takeda Launches New Subsidiary in Ecuador
Biopharmaceuticals
 HSMN NewsFeed - 17 Dec 2012
Naurex Completes $38 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 6 Nov 2012
Takeda to Acquire Envoy Therapeutics, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Oct 2012
Takeda and Millennium Announce European Conditional Marketing Authorization for ADCETRIS(R) (Brentuximab Vedotin)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Oct 2012
Zyngenia, Inc. Expands Its Board of Directors with Leading Life Sciences Business Executives Christian Itin and Jason Rhodes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2012
Wockhardt launches generic version of anti-ulcer drug Prevacid(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 Sep 2012
Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Sep 2012
Revestive(R) (teduglutide) Receives European Marketing Authorization for the Treatment of Adults with Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 17 Aug 2012
Ranbaxy Launches Authorized Generic Of Pioglitazone In The U.S.
Biopharmaceuticals Generics Endocrinology
 HSMN NewsFeed - 22 Jun 2012
Takeda Receives Positive CHMP Opinion for Teduglutide (Revestive(R)) for Patients with Short Bowel Syndrome
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 15 Jun 2012
ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Jun 2012
Former Pfizer Worldwide Business Development Director Joins Australian Drug Development Company Agenix
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2012
Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 May 2012
Takeda Announces GEMINI II Trial of Vedolizumab in Patients with Moderately to Severely Active Crohn’s Disease Met Primary Endpoints of Improvement in Clinical Remission in Induction and Maintenance Phases
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 11 Apr 2012
Takeda to Acquire URL Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Jan 2012
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2011
FDA Approves Addition of Sustained Overall Survival Advantage (5-year follow-up) to Label for VELCADE(R) in Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Sep 2011
Takeda Completes Acquisition and Names New CEO of Nycomed
Biopharmaceuticals Personnel Mergers & Acquisitions
 HSMN NewsFeed - 1 Aug 2011
Nycomed US Inc. Names Brian A. Markison as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2011
BioSante Pharmaceuticals Announces Management Team Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2011
Takeda to Acquire Nycomed
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 May 2011
Nycomed's US Dermatology Business to Become an Independent Entity Following Nycomed's Acquisition by Takeda
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 17 Feb 2011
Orexigen(R) Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2011
FDA Issues Complete Response to New Drug Application for Contrave(R) for the Management of Obesity
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Dec 2010
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet (Pirfenidone) in Europe
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2010
Aperio Continues Leadership in Digital Pathology
Devices Diagnostics
 HSMN NewsFeed - 10 Dec 2010
Dr. Steve Kaldor Joins Furiex Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2010
Alnylam Elects Marsha Fanucci to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Dec 2010
Orexigen(R) Therapeutics' Investigational Drug Contrave(R) Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Nov 2010
Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2010
Forest Announces FDA Approval of Teflaro(TM) (ceftaroline fosamil) for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Sep 2010
Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 7 Sep 2010
FDA Advisory Committee Recommends Approval of Forest Laboratories' Ceftaroline Fosamil for the Treatment of Community Acquired Bacterial Pneumonia and Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Sep 2010
Santhera and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 26 Aug 2010
XOMA Appoints Jack L. Wyszomierski to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2010
Actient Pharmaceuticals, LLC Closes Transaction to License and Acquire Specialty Pharmaceutical Products from UCB
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 21 Jun 2010
New Head-to-Head Phase 3 Study Evaluated Systolic Blood Pressure Reduction of Investigational Compound Azilsartan Medoxomil Compared to Valsartan
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 10 May 2010
Takeda to Co-Promote VELCADE(R) (bortezomib) for Injection in Japan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Apr 2010
Takeda Provides Update on Patent Litigation for ACTOS(R) (pioglitazone HCl) and ACTOplus met(R) (pioglitazone HCl and metformin HCl) in the U.S.
Biopharmaceuticals Litigation Endocrinology
 HSMN NewsFeed - 7 Apr 2010
Tris Pharma Announces Key Executive Hiring of Vice President of Corporate Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 Apr 2010
AMAG Pharmaceuticals and Takeda Pharmaceutical Company Announce Strategic Collaboration for Feraheme(R) in All Therapeutic Indications in Select Ex-US Territories, Including Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Mar 2010
Epizyme Expands Leadership Team, Appointing Robert Gould, Ph.D. as CEO and Jason Rhodes as EVP and CBO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Mar 2010
Ranbaxy Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Mar 2010
Watson Announces Actos(R) Patent Challenge Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 22 Feb 2010
Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2010
Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 9 Feb 2010
Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors With Plavix(R) (Clopidogrel Bisulfate)
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2010
FDA Approves Addition of Sustained Overall Survival Benefit to Label for VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Dec 2009
Forest Laboratories Announces Acquisition of Additional Rights Related to NXL 104, a Novel Broad-Spectrum Beta-Lactamase Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Dec 2009
Seattle Genetics and Millennium: The Takeda Oncology Company Announce Strategic Collaboration for Novel Late-Stage Lymphoma Program Brentuximab Vedotin (SGN-35)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Dec 2009
VELCADE(R) (Bortezomib) for Injection Based Combinations Deliver Two-Year Overall Survival Rates of Up to 88 Percent in Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Nov 2009
Four Senior Executives Join Orexigen(R) Therapeutics Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2009
XOMA Appoints Jim Neal Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2009
Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTab
Biopharmaceuticals Generics Drug Delivery Litigation
 HSMN NewsFeed - 14 Oct 2009
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2009
FDA Grants Priority Review Status to Supplement Containing Long-Term Survival Data for VELCADE(R) (bortezomib) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Sep 2009
FDA to Review Supplement Containing Long-Term Survival Data For VELCADE(R) (bortezomib) For Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Aug 2009
Forest Laboratories and AstraZeneca to Co-Develop and Commercialize a Late Stage Next Generation Anti-Infective
Biopharmaceuticals
 HSMN NewsFeed - 29 Jun 2009
Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 May 2009
Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 13 May 2009
FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 7 May 2009
Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 May 2009
Takeda Global Research & Development Center, Inc., U.S. Names Dr. Azmi Nabulsi President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2009
ULORIC(R) (febuxostat) 40-mg and 80-mg Tablets Now Available for the Chronic Management of Hyperuricemia in Patients with Gout
Biopharmaceuticals
 HSMN NewsFeed - 23 Feb 2009
KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for the Treatment of GERD
Biopharmaceuticals
 HSMN NewsFeed - 14 Feb 2009
FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Jan 2009
FDA Approves KAPIDEX(TM) (Dexlansoprazole) Delayed Release Capsules for the Treatment of GERD
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 15 Jan 2009
XOMA Announces Workforce Reduction
Biopharmaceuticals
 HSMN NewsFeed - 6 Jan 2009
Horizon Therapeutics Announces Senior Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2008
Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jun 2008
Affymax(R) Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 May 2008
AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 27 May 2008
Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
Takeda Completes Acquisition of Millennium
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 May 2008
Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 May 2008
Abbott, Takeda Conclude TAP Joint Venture
Biopharmaceuticals
 HSMN NewsFeed - 29 Apr 2008
Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Apr 2008
Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Apr 2008
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Mar 2008
New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 26 Mar 2008
Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 19 Mar 2008
Takeda Announces New U.S. Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2008
Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
Biopharmaceuticals
 HSMN NewsFeed - 10 Mar 2008
XOMA Appoints Mary L. Anderson as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2008
Sucampo Pharma Europe Announces the Filing of a Marketing Authorisation Application of Lubiprostone in the United Kingdom with Eight Additional European Countries to Follow
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Feb 2008
Sucampo Pharmaceuticals Appoints John C. Wright, Retired Ernst & Young Partner, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2008
Sucampo Pharmaceuticals Expands Global Presence as European Subsidiary Opens New Office in Basel, Switzerland
Biopharmaceuticals
 HSMN NewsFeed - 7 Feb 2008
MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2008
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Jan 2008
ReachMD Appoints Pharmaceutical Veteran as Executive Vice President of Sales and Business Development
Personnel
 HSMN NewsFeed - 1 Nov 2007
Bentley Announces Its First Product Approval in France
Biopharmaceuticals Generics Regulatory
 HSMN NewsFeed - 15 Oct 2007
Sucampo Pharmaceuticals Presents Data on Cobiprostone at American College of Gastroenterology Annual Scientific Meeting
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 8 Oct 2007
Steven Engle Appointed Chairman of XOMA
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2007
ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients With Type 2 Diabetes
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 13 Sep 2007
Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
Biopharmaceuticals
 HSMN NewsFeed - 11 Sep 2007
Takeda Statement on ACTOS(R) (pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 4 Sep 2007
Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2007
IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2007
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 6 Aug 2007
XOMA Appoints Steven B. Engle President, Chief Executive Officer and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2007
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
Biopharmaceuticals HIV/AIDS Venture Capital Personnel
 HSMN NewsFeed - 31 Jul 2007
Affymax Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2007
Ambrx Appoints Stephen Kaldor Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2007
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2007
Takeda Revises ACTOS(R) (pioglitazone HCl) Prescribing Label
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 21 May 2007
New Study Demonstrates That Lubiprostone May Improve Symptom Relief Rates in Adults With Irritable Bowel Syndrome With Constipation (IBS-C)
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 15 May 2007
Array BioPharma Appoints John Yates, MB ChB, MD, to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2007
Lexicon Genetics Changes Name to Lexicon Pharmaceuticals as Drug Development Pipeline Progresses
Biopharmaceuticals
 HSMN NewsFeed - 12 Apr 2007
XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 4 Apr 2007
DOR BioPharma Announces Initiation of Clinical Development Program for Oral Leuprolide
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 3 Apr 2007
Wyeth Completes Purchase of Wyeth K.K. Japan
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Mar 2007
Lexicon Genetics Appoints Tamar Howson Executive Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2007
Takeda to Acquire Paradigm Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Feb 2007
Lexicon Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2007
XOMA Announces Planned Retirement of Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2007
Takeda and TAP to Promote Sucampo's AMITIZA(R) in the United States
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 19 Jan 2007
Takeda Global Research & Development Center, Inc. Names Dr. Mehmood Khan President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jan 2007
Takeda Pharmaceuticals North America Names Vice President of Human Resources and Administration
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2007
Ambit Biosciences Appoints Wendell Wierenga, Ph.D., as Executive Vice President of Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2007
Sucampo Appoints Veteran Financial Executive Ronald W. Kaiser as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2006
Cerexa to Be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Dec 2006
Forest Laboratories Announces Acquisition of Cerexa, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Nov 2006
New Data Show ACTOS(R) (pioglitazone HCl) Halted Progression of Atherosclerosis as Indicated by CIMT in Patients With Type 2 Diabetes
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2006
AMITIZA(TM) (lubiprostone) Phase III Constipation Trial Results Demonstrate Improvements in Symptoms of Irritable Bowel Syndrome With Constipation
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 20 Oct 2006
Takeda Celebrates U.S. Growth with Grand Opening of New Home Office
Biopharmaceuticals
 HSMN NewsFeed - 3 Oct 2006
Sucampo Pharmaceuticals Completes Planned Consolidation of European and Asian Affiliates; Announces Strategic Alignment of Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2006
Ipsen: EMEA's Validation of Febuxostat's Marketing Authorization Application in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Oct 2006
Xenon and Takeda Announce Agreement To Develop and Commercialize XEN401 for Pain in Japan and Certain Asian Countries
Biopharmaceuticals
 HSMN NewsFeed - 29 Sep 2006
TAP Enters Into Co-Promotion Agreement for Famvir(R)
Biopharmaceuticals
 HSMN NewsFeed - 14 Sep 2006
ACTOS(R) (pioglitazone HCl) Demonstrates Significant Improvements in Cardiovascular Outcomes for High-Risk Patients With Type 2 Diabetes
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 21 Jul 2006
Takeda Announces Start of Phase 3 Clinical Program in the U.S. of Fixed Dose Combination Product of Actos(R) + TAK-536 for Treatment of Patients with Type 2 Diabetes Associated with Hypertension
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 20 Jul 2006
ImClone Systems and Merck KGaA Amend and Supplement ERBITUX Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 May 2006
New Study Demonstrates That AMITIZA(TM) (lubiprostone) May Help Improve Symptoms of Irritable Bowel Syndrome With Constipation
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 21 May 2006
AMITIZA(TM) (Lubiprostone) Shown Effective and Well-Tolerated in People Older than Age 65, a Population Considerably Affected by Chronic Idiopathic Constipation
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 4 May 2006
Combined Use of ATACAND(R) (candesartan cilexetil) and ACE Inhibitor Improves Heart Failure Outcomes More Than ACE Inhibitor Alone
Biopharmaceuticals Cardiology
Return to NewsFeed  

 Additional items found! 70

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 70 additional stories matching:
Takeda Pharmaceutical
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.